For the quarter ended July 2025, Phreesia (PHR) reported revenue of $117.26 million, up 14.8% over the same period last year. EPS came in at $0.01, compared to -$0.31 in the year-ago quarter.
The reported revenue represents a surprise of +0.7% over the Zacks Consensus Estimate of $116.45 million. With the consensus EPS estimate being -$0.07, the EPS surprise was +114.29%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Phreesia performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Average healthcare services Clients: 4,467 versus the three-analyst average estimate of 4,475.
- Patient payment volume: $1.25 billion versus $1.18 billion estimated by three analysts on average.
- Payment facilitator volume percentage: 82% compared to the 82.2% average estimate based on two analysts.
- Revenus- Subscription and related services: $53.7 million compared to the $55.27 million average estimate based on six analysts. The reported number represents a change of +10.5% year over year.
- Revenus- Network solutions: $35.16 million versus the six-analyst average estimate of $33.25 million. The reported number represents a year-over-year change of +24.7%.
- Revenus- Payment processing fees: $28.39 million versus the six-analyst average estimate of $27.9 million. The reported number represents a year-over-year change of +12.2%.
View all Key Company Metrics for Phreesia here>>>
Shares of Phreesia have returned +12.3% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Phreesia, Inc. (PHR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
